Cipla Limited
CIPLA
Classificação em ações
#1818
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Preço da ação
$14.61
Valor de mercado
$11.80B
Variação (1 dia)
-0.12%
Variação (1 ano)
-18.47%
País
IN
Negociar Cipla Limited (CIPLA)
Categoria
Healthcare
Histórico de rendimento de dividendos para Cipla Limited (CIPLA)
O rendimento de dividendos (TTM) da Cipla Limited (símbolo da ação: CIPLA) em 2024-03-31 é: 0.57%
Rendimento médio dos dividendos nos últimos 5 anos: 0.50%
Rendimento médio dos dividendos nos últimos 5 anos: 0.50%
Histórico de rendimento de dividendos para Cipla Limited (CIPLA) de 2004 a 2026
Rendimento de dividendos no final de cada ano (TTM)
| Ano | Rendimento de Dividendos | Alterar |
|---|---|---|
| 2026 (TTM) | 0.98% | 8.89% |
| 2025 | 0.90% | 57.89% |
| 2024 | 0.57% | 1.79% |
| 2023 | 0.56% | 14.29% |
| 2022 | 0.49% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | 1.66% | 191.23% |
| 2019 | 0.57% | 62.86% |
| 2018 | 0.35% | 2.94% |
| 2017 | 0.34% | -12.82% |
| 2016 | 0.39% | 39.29% |
| 2015 | 0.28% | -46.15% |
| 2014 | 0.52% | 0.00% |
| 2013 | 0.52% | -21.21% |
| 2012 | 0.66% | -24.14% |
| 2011 | 0.87% | 50.00% |
| 2010 | 0.58% | -36.26% |
| 2009 | 0.91% | 0.00% |
| 2008 | 0.91% | 7.06% |
| 2007 | 0.85% | 60.38% |
| 2006 | 0.53% | -54.70% |
| 2005 | 1.17% | 37.65% |
| 2004 | 0.85% | 0.00% |
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
| Empresa | Rendimento de Dividendos | País |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
